[{"uuid": "2d1843b5-a0d5-3c60-959d-cf9c6690e37f", "title": "Aclaris Therapeutics Announces Formation of New Scientific Advisory Board", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/aclaris-therapeutics-announces-formation-scientific-210100795.html", "providerPublishTime": 1738270860, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/CUkDs6ThkLhduqpJb_MUeQ--~B/aD0zNzc7dz04OTc7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/0e59e094d4da57aca49e8aec2a77b26b", "width": 897, "height": 377, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/WFVQa9CaVQ_FuRgAD7Gvew--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/0e59e094d4da57aca49e8aec2a77b26b", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ACRS"]}, {"uuid": "1cdeae28-d96c-3adb-a9bc-c869072e49a7", "title": "Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/aclaris-therapeutics-announces-inducement-grants-213000876.html", "providerPublishTime": 1736199000, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/CUkDs6ThkLhduqpJb_MUeQ--~B/aD0zNzc7dz04OTc7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/0e59e094d4da57aca49e8aec2a77b26b", "width": 897, "height": 377, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/WFVQa9CaVQ_FuRgAD7Gvew--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/0e59e094d4da57aca49e8aec2a77b26b", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ACRS"]}, {"uuid": "936a2e11-1128-3128-a9e6-104f2be47538", "title": "HC Wainwright Upgrades Aclaris Therapeutics to Buy From Neutral, $20 Price Target", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/hc-wainwright-upgrades-aclaris-therapeutics-120425176.html", "providerPublishTime": 1734955465, "type": "STORY", "relatedTickers": ["ACRS"]}, {"uuid": "2cd15bae-b1c5-35a9-abce-b72f41c62e57", "title": "Aclaris Therapeutics Files Statement for Share Resale by Stockholders; Stock Rises After Hours", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/aclaris-therapeutics-files-statement-share-222411621.html", "providerPublishTime": 1734647051, "type": "STORY", "relatedTickers": ["ACRS"]}, {"uuid": "21d43eab-d047-329e-84cc-606e0fd799ff", "title": "Aclaris Therapeutics (ACRS) Reports Q3 Loss, Misses Revenue Estimates", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/aclaris-therapeutics-acrs-reports-q3-130507469.html", "providerPublishTime": 1730898307, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/kz0ozt3ejWMPXKci2JxOBw--~B/aD03NTQ7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/d7dcbe11345e3f8e5e71e6827fe3c4c9", "width": 1000, "height": 754, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/9DuI9CAB81x7COnzMbUTGw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/d7dcbe11345e3f8e5e71e6827fe3c4c9", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ACRS"]}, {"uuid": "9f4f13ba-0817-39d1-a53e-53d9f2b6c672", "title": "ACRS Stock Up on Licensing Deal With Biosion for Two Immunology Drugs", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/acrs-stock-licensing-deal-biosion-141900379.html", "providerPublishTime": 1732025940, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/KEj1lCkxRqndrrMrF3m.HA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c7450ec9df154559fbeb393640d6629", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/L9oXp_PBujUXs0r0RIkKrg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/9c7450ec9df154559fbeb393640d6629", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ACRS", "PFE"]}, {"uuid": "712bd1cf-c47f-3d4d-863f-782717853072", "title": "Pony AI, Thermo Fisher initiated: Wall Street's top analyst calls", "publisher": "The Fly", "link": "https://finance.yahoo.com/news/pony-ai-thermo-fisher-initiated-143543015.html", "providerPublishTime": 1734964543, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/zUit8GQVW5kcaTZHEPMI9Q--~B/aD02Mjg7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/the_fly_169/5039a5ccc6ec98e1b92bc672330bfcec", "width": 1200, "height": 628, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/IPH9wCP.ftudEFOX7xr1MA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/the_fly_169/5039a5ccc6ec98e1b92bc672330bfcec", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["TMO"]}, {"uuid": "8027d954-872f-38f7-98e6-ad757aa074b5", "title": "News Flash: Analysts Just Made A Meaningful Upgrade To Their Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Forecasts", "publisher": "Simply Wall St.", "link": "https://finance.yahoo.com/news/news-flash-analysts-just-made-111446349.html", "providerPublishTime": 1731410086, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/TLyt5D16lsSwRjJRVjlUTA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/fd5474a7eee0c5f442903b68fe63249b", "width": 1194, "height": 432, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/z2gq8yB1R5a4THvSEUeVaQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/fd5474a7eee0c5f442903b68fe63249b", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ACRS"]}, {"uuid": "823c6c56-27ba-3106-b6fe-57a107b40f5d", "title": "Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates", "publisher": "Simply Wall St.", "link": "https://finance.yahoo.com/news/aclaris-therapeutics-inc-nasdaq-acrs-141856273.html", "providerPublishTime": 1731161936, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/TLyt5D16lsSwRjJRVjlUTA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/fd5474a7eee0c5f442903b68fe63249b", "width": 1194, "height": 432, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/z2gq8yB1R5a4THvSEUeVaQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/fd5474a7eee0c5f442903b68fe63249b", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ACRS"]}, {"uuid": "f5c84556-e6fd-35ce-8d73-b67724d7fa2e", "title": "Aclaris Therapeutics upgraded to Buy from Hold at Jefferies", "publisher": "TipRanks", "link": "https://finance.yahoo.com/news/aclaris-therapeutics-upgraded-buy-hold-101103162.html", "providerPublishTime": 1732097463, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/c8pJ6Hc13EFaByQh6DEJ0A--~B/aD0xOTI7dz0xOTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/tipranks_452/0176eac0ccabb4c894de3218c38cf5eb", "width": 192, "height": 192, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/bircVCqs.PWolEadE6JkKg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/tipranks_452/0176eac0ccabb4c894de3218c38cf5eb", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ACRS"]}, {"uuid": "32c97e92-04a8-3350-b020-4393f9134533", "title": "Aclaris Therapeutics upgraded to Buy from Neutral at BTIG", "publisher": "TipRanks", "link": "https://finance.yahoo.com/news/aclaris-therapeutics-upgraded-buy-neutral-023012138.html", "providerPublishTime": 1732069812, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/EWL56DETwmfBFfnXlOrIoQ--~B/aD0xOTI7dz0xOTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/tipranks_452/8948b64e92d23cb05c63afbc8ed98e4c", "width": 192, "height": 192, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/3wU7lIZ_DbNiCCYuX_1WbA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/tipranks_452/8948b64e92d23cb05c63afbc8ed98e4c", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ACRS"]}, {"uuid": "dcdcd594-9bde-36d6-be2c-18e29072ea39", "title": "Aclaris Therapeutics Reports Third Quarter 2024 Financial Results and Provides a Corporate Update", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/aclaris-therapeutics-reports-third-quarter-120000209.html", "providerPublishTime": 1730894400, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/CUkDs6ThkLhduqpJb_MUeQ--~B/aD0zNzc7dz04OTc7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/0e59e094d4da57aca49e8aec2a77b26b", "width": 897, "height": 377, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/WFVQa9CaVQ_FuRgAD7Gvew--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/0e59e094d4da57aca49e8aec2a77b26b", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ACRS"]}]